Nutritional High International Inc Stock Deutsche Boerse AG
Equities
Pharmaceuticals
Sales 2021 | 96.07K 70.32K 64.59K | Sales 2022 | 6.25M 4.57M 4.2M | Capitalization | 3.26M 2.39M 2.19M |
---|---|---|---|---|---|
Net income 2021 | -1M -732K -672K | Net income 2022 | -19M -13.91M -12.78M | EV / Sales 2021 | 191 x |
Net Debt 2021 | 6.1M 4.46M 4.1M | Net Debt 2022 | 11.34M 8.3M 7.63M | EV / Sales 2022 | 2.34 x |
P/E ratio 2021 |
-7.32
x | P/E ratio 2022 |
-0.09
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 80.7% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 23-03-30 | |
Michael Willetts
DFI | Director of Finance/CFO | - | 23-03-30 |
Adam Szweras
CHM | Chairman | 52 | 14-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adam Szweras
CHM | Chairman | 52 | 14-07-06 |
Chief Tech/Sci/R&D Officer | - | 15-06-10 | |
Austin Birch
BRD | Director/Board Member | - | 23-01-19 |
1st Jan change | Capi. | |
---|---|---|
+3.99% | 3.12B | |
+99.71% | 1.88B | |
+90.48% | 64.64M | |
+300.00% | 58.35M |